Skip to content

Effects of Erector Spinae Plane Block on Postoperative Pain Following Lumbar Fusion Surgery

Opioid Usage and Patient Reported Outcome Comparison Following Erector Spinae Plane Block or Subcutaneous Anesthetic in Spinal Fusion Procedures

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06528288
Enrollment
66
Registered
2024-07-30
Start date
2024-09-13
Completion date
2027-07-01
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Local, Fusion of Spine, Lumbar Region, Opioid Use, Pain, Postoperative

Keywords

Erector Spinae Plane Block, Spinal Fusion, Patient Reported Outcomes, Opioid Usage

Brief summary

The purpose of this study is to determine if the method for injecting local anesthesia affects patients' pain and opioid usage after surgery. The investigators will compare subcutaneous anesthesia, injections of anesthesia under the skin, to a method called erector spinae plane block (ESPB). An ESPB injection involves placing local anesthesia along the muscles and bones in the back, using a special type of x-ray called fluoroscopy for guidance. The Investigators will use patient reported outcomes (PROs) and track subjects' opioid usage to find out if there is a difference between ESPB and subcutaneous anesthesia. The investigators hypothesize that patients who get ESPB injections will use less opioids and report less pain after lumbar fusion surgery compared to patients who receive subcutaneous anesthesia injections.

Interventions

PROCEDUREErector Spinae Plane Block

The erector spinae plane block (ESPB) is a method for injecting local anesthesia to reduce pain related to a surgical procedure. The anesthesia is theorized to spread along the paraspinal fascia and anesthetize a larger area, resulting in patients reporting less pain and using less opioids postoperatively.

PROCEDURESubcutaneous Anesthesia

Subcutaneous anesthesia injection involves placement of local anesthesia under the skin around the surgical incision. This is thought to reduce pain from the incision site postoperatively.

Sponsors

University of Massachusetts, Worcester
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participants will be masked to the treatment arm. The research team (outcomes assessors) involved in evaluation of subjects will be blinded to the treatment arm.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The individual has signed and dated a study specific informed consent form approved by the Institutional Review Board at UMMHC. * The individual is at least 18 years of age. * The individual is skeletally mature (over the age of 18). * The patient is scheduled for a one or two level lumbar spinal fusion.

Exclusion criteria

* Patients unable to consent for themselves. * Pregnant women. * Non-English speaking subjects. * Prisoners. * Spinal fusion procedures for a diagnosis of fracture, tumor, and/or infection. * Patients who have used greater than 150 morphine milligram equivalents of opioids in the month prior to their operation. * Patients with a body mass index (BMI) of 40 or greater.

Design outcomes

Primary

MeasureTime frameDescription
MOS 36 Item Short Form Health Status Survey (SF-36)3 monthsQuestionnaire related to a patient's general health, bodily pain, physical function, and mental health. Scoring includes eight scaled scores, which are the weighted sums of the questions in their section. Scales are converted into a 0-100 scale. The lower the score the more disability. The higher the score the more functionality and therefore indicating better outcome.
Oswestry Disability Index3 monthsQuestionnaire related to a patient's back pain and its impact on their day-to-day activities. There are 10 questions, each weighted from 0-5 points. The point total of each question is added together to give a final scaled score ranging from 0-50. Lower scores near 0 are indicative of better outcome and less disability, while higher scores near 50 indicate worse outcomes and more disability.
Postoperative Opioid Usage2 weeksThis is a tracking sheet for the amount of opioid medications used in the first 2 weeks of postoperative recovery.

Countries

United States

Contacts

CONTACTMichael P Stauff, MD
Michael.Stauff@umassmed.edu508-334-9764
PRINCIPAL_INVESTIGATORMichael Stauff, MD

UMass Chan Medical School

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026